STOCK TITAN

[Form 4] ALBEMARLE CORP Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Albemarle (ALB) Form 4: The company’s General Counsel & Secretary reported a sale of 172 shares of common stock on 10/24/2025 at $105 per share (Transaction Code: S). The filing states the trade was executed under a Rule 10b5-1 trading plan adopted on March 13, 2025, prior to the individual becoming an executive officer. Following the transaction, the insider directly holds 11,483 shares.

Albemarle (ALB) Modulo 4: Il Consigliere Generale e Segretario della società ha riportato una vendita di 172 azioni ordinarie il 24/10/2025 a 105 dollari per azione (Codice di transazione: S). Il deposito indica che l'operazione è stata eseguita secondo un piano di trading Rule 10b5-1 adottato il 13 marzo 2025, prima che l'individuo diventasse dirigente. Dopo la operazione, l'interno detiene direttamente 11.483 azioni.

Albemarle (ALB) Formulario 4: El Consejero General y Secretario de la empresa reportó la venta de 172 acciones comunes el 24/10/2025 a 105 dólares por acción (Código de Transacción: S). El escrito indica que la operación se ejecutó bajo un plan de trading Rule 10b5-1 adoptado el 13 de marzo de 2025, antes de que la persona se convirtiera en ejecutivo. Tras la operación, el insider posee directamente 11,483 acciones.

Albemarle (ALB) 양식 4: 회사의 일반 법무담당 고문 겸 비서는 2025년 10월 24일 주당 105달러로 보통주 172주를 매도했다고 보고했습니다 (거래 코드: S). 공시는 거래가 2025년 3월 13일에 채택된 Rule 10b5-1 거래 계획에 따라 실행되었으며, 해당 인물이 임원이 되기 전에 이루어졌다고 명시하고 있습니다. 거래 이후 내부자는 직접 11,483주를 보유합니다.

Albemarle (ALB) Formulaire 4 : Le conseiller juridique général et secrétaire de la société a déclaré une vente de 172 actions ordinaires le 24/10/2025 à 105 dollars l'action (Code de transaction : S). Le dossier indique que la transaction a été exécutée dans le cadre d'un plan de trading Rule 10b5-1 adopté le 13 mars 2025, avant que la personne ne devienne dirigeant. Suite à la transaction, l'initié détient directement 11 483 actions.

Albemarle (ALB) Formular 4: Der General Counsel & Secretary des Unternehmens meldete einen Verkauf von 172 Stammaktien am 24.10.2025 zu 105 USD pro Aktie (Transaktionscode: S). Die Einreichung gibt an, dass der Handel im Rahmen eines Rule 10b5-1-Handelsplans erfolgte, der am 13. März 2025 genehmigt wurde, bevor die Person Führungskraft wurde. Nach der Transaktion hält der Insider direkt 11.483 Aktien.

ألبيمارل (ALB) النموذج 4: أبلغ المستشار القانوني العام والأمين التنفيذي للشركة عن بيع 172 سهماً من الأسهم العادية في 24/10/2025 بسعر 105 دولارات للسهم (رمز الصفقة: S). تشير الإيداعات إلى أن الصفقة نفذت بموجب خطة تداول Rule 10b5-1 التي اعتمدت في 13 مارس 2025، قبل أن يصبح الشخص موظفاً تنفيذياً. بعد الصفقة يمتلك الداخل مباشرة 11,483 سهماً.

Positive
  • None.
Negative
  • None.

Albemarle (ALB) Modulo 4: Il Consigliere Generale e Segretario della società ha riportato una vendita di 172 azioni ordinarie il 24/10/2025 a 105 dollari per azione (Codice di transazione: S). Il deposito indica che l'operazione è stata eseguita secondo un piano di trading Rule 10b5-1 adottato il 13 marzo 2025, prima che l'individuo diventasse dirigente. Dopo la operazione, l'interno detiene direttamente 11.483 azioni.

Albemarle (ALB) Formulario 4: El Consejero General y Secretario de la empresa reportó la venta de 172 acciones comunes el 24/10/2025 a 105 dólares por acción (Código de Transacción: S). El escrito indica que la operación se ejecutó bajo un plan de trading Rule 10b5-1 adoptado el 13 de marzo de 2025, antes de que la persona se convirtiera en ejecutivo. Tras la operación, el insider posee directamente 11,483 acciones.

Albemarle (ALB) 양식 4: 회사의 일반 법무담당 고문 겸 비서는 2025년 10월 24일 주당 105달러로 보통주 172주를 매도했다고 보고했습니다 (거래 코드: S). 공시는 거래가 2025년 3월 13일에 채택된 Rule 10b5-1 거래 계획에 따라 실행되었으며, 해당 인물이 임원이 되기 전에 이루어졌다고 명시하고 있습니다. 거래 이후 내부자는 직접 11,483주를 보유합니다.

Albemarle (ALB) Formulaire 4 : Le conseiller juridique général et secrétaire de la société a déclaré une vente de 172 actions ordinaires le 24/10/2025 à 105 dollars l'action (Code de transaction : S). Le dossier indique que la transaction a été exécutée dans le cadre d'un plan de trading Rule 10b5-1 adopté le 13 mars 2025, avant que la personne ne devienne dirigeant. Suite à la transaction, l'initié détient directement 11 483 actions.

Albemarle (ALB) Formular 4: Der General Counsel & Secretary des Unternehmens meldete einen Verkauf von 172 Stammaktien am 24.10.2025 zu 105 USD pro Aktie (Transaktionscode: S). Die Einreichung gibt an, dass der Handel im Rahmen eines Rule 10b5-1-Handelsplans erfolgte, der am 13. März 2025 genehmigt wurde, bevor die Person Führungskraft wurde. Nach der Transaktion hält der Insider direkt 11.483 Aktien.

ألبيمارل (ALB) النموذج 4: أبلغ المستشار القانوني العام والأمين التنفيذي للشركة عن بيع 172 سهماً من الأسهم العادية في 24/10/2025 بسعر 105 دولارات للسهم (رمز الصفقة: S). تشير الإيداعات إلى أن الصفقة نفذت بموجب خطة تداول Rule 10b5-1 التي اعتمدت في 13 مارس 2025، قبل أن يصبح الشخص موظفاً تنفيذياً. بعد الصفقة يمتلك الداخل مباشرة 11,483 سهماً.

阿尔贝马尔(ALB)表格 4: 公司的总法律顾问兼秘书在 2025-10-24 以每股 105 美元出售了 172 股普通股(交易代码:S)。申报称该交易是在 2025-03-13 通过的 Rule 10b5-1 交易计划下执行的,发生在该个人成为执行官之前。交易完成后,该内部人士直接持有 11,483 股。

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Krupa Ander C.

(Last) (First) (Middle)
4250 CONGRESS STREET
SUITE 900

(Street)
CHARLOTTE NC 28209

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ALBEMARLE CORP [ ALB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
General Counsel & Sec
3. Date of Earliest Transaction (Month/Day/Year)
10/24/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/24/2025 S 172(1) D $105 11,483 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sale reported in this Form 4 was effectuated pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2025, prior to the Reporting Person becoming an Executive Officer.
Remarks:
/s/ Rebekah Richards, Attorney-in-Fact 10/28/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did ALB report?

A sale of 172 shares of common stock at $105 on 10/24/2025 (Code S).

Who made the transaction at Albemarle (ALB)?

The company’s General Counsel & Secretary.

Was the ALB trade under a Rule 10b5-1 plan?

Yes. It was executed under a Rule 10b5-1 trading plan adopted on March 13, 2025.

How many ALB shares does the insider hold after the sale?

The insider directly holds 11,483 shares after the transaction.

What was the ownership form reported?

The filing lists ownership as Direct (D).

What was the transaction code on the Form 4?

The transaction is coded S for an open market or private sale of non-derivative securities.
Albemarle Corp

NYSE:ALB

ALB Rankings

ALB Latest News

ALB Latest SEC Filings

ALB Stock Data

11.38B
117.10M
0.41%
98.74%
10.83%
Specialty Chemicals
Plastic Materials, Synth Resins & Nonvulcan Elastomers
Link
United States
CHARLOTTE